PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
104 hedge funds and large institutions have $115M invested in Aratana Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
41% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 27
44% less capital invested
Capital invested by funds: $206M → $115M (-$90.6M)
Holders
104
Holding in Top 10
2
Calls
$387K
Puts
$98K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$5.4M | |
| 3 | +$3.36M | |
| 4 |
MCM
Moore Capital Management
New York
|
+$1.08M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$1.06M |
Top Sellers
| 1 | -$33.9M | |
| 2 | -$3.85M | |
| 3 | -$2.06M | |
| 4 |
Millennium Management
New York
|
-$1.9M |
| 5 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.88M |